SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Mazzarella who wrote (399)9/6/1996 7:15:00 PM
From: WWS   of 4342
 
Richard, A real treasure trove! And to think that all this research was available as early as 1988! This article also contains a powerful argument as to why we can't get too excited about AndroVir until the Phase 1 trials are released publicly. The experiment described here, and PRLN's initial research on AndroVir, relate only to "IN VITRO" (i.e., test tube) conditions. This study clearly states that the concentration of herbal extracts used in vitro are probably much higher than the level that could be attained in the blood of a human infected with HIV. I believe that our little society of snoopers could market our investigative services to the pharmacological industry!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News